Author Disclosures
PDF Print E-mail

Click here to view organization disclosures

Christopher Bever, MD
Christopher T. Bever, Jr., M.D., M.B.A.
Professor, Departments of Neurology, Pharmacology and Experimental Therapeutics and Physical Therapy and Rehabilitation Science, University of Maryland School of Medicine
Director, VA MS Center of Excellence - East
Associate Chief of Staff for Research and Development, VA Maryland Health Care System

Speakers Bureau: none
Consulting: none
Royalties: Abraxis, Inc.
Stocks, Bonds, Options: none
Other Equity Interest: none
Patents, Intellectual Property Rights: Co-holder on patent on the use of hematogenous stem cells in neurological diseases
Grant Support: Department of Veterans Affairs, National MS Society
Clinical Procedures: none
Expert Testimony: none
Bruce Cohen
Davee Department of Neurology and Clinical Neurosciences, Feinberg School of Medicine, Northwestern University
Chair Clinical Care Committee, Chair National Clinical Advisory Board / Executive Committee, National Multiple Sclerosis Society
Member and Immediate Past Chair / Executive Committee, Multiple Sclerosis Section, American Academy of Neurology

Speakers Bureau: none
Consulting: Acorda, EMD Serono, Genentech, Questcor, and Teva Neuroscience
Royalties: none
Stocks, Bonds, Options: (Common Stock) Abbott Laboratories, CVS-Caremark
Other Equity Interest: none
Patents, Intellectual Property Rights: none
Grant Support:
  • Funded Institutional research through Northwestern University: Biogen Idec, EMD Serono, Novartis, and Hoffman La Roche
Clinical Procedures: none
Expert Testimony: none
Julie Cox
Manager, Clinical Practice Publications, American Academy of Neurology

Nothing to disclose
Gay Falkowski
Editorial Coordinator, Multiple Sclerosis Foundation

Nothing to disclose
Andrea L. Griesé
Vice President of Communications & Marketing, Multiple Sclerosis Association of America

Nothing to disclose
June Halper, APN-C, MSCN, FAAN
Chief Executive Officer, Consortium of Multiple Sclerosis Centers
Executive Director, International Organization of Multiple Sclerosis Nurses

Speakers Bureau: none
Consulting: Biogen Idec
Royalties: Demos Medical Publishing
Stocks, Bonds, Options: none
Other Equity Interest: none
Patents, Intellectual Property Rights: none
Grant Support: none
Clinical Procedures: none
Expert Testimony: none
David Jones, MD
Speakers Bureau: None (not allowed)
Consulting: Individual contracts with Biogen Idec, Genzyme, Novartis; Under institutional agreement with Biogen Idec, Genzyme, Questcor
Royalties: None Stocks, Bonds, Options: None
Other Equity Interest: None
Patents, Intellectual Property Rights: None
Grant Support: NMSS (Vitamin D study)
Clinical Procedures: None
Expert Testimony: Only one case (malpractice in patient with undiagnosed neurosarcoidosis
Rosalind Kalb, PhD
Vice President, Professional Resource Center, National Multiple Sclerosis Society

Speakers Bureau: none
Consulting: none
Royalties: Demos Medical Publishing, Wiley Publishing
Stocks, Bonds, Options: none
Other Equity Interest: none
Patents, Intellectual Property Rights: none
Grant Support: none
Clinical Procedures: none
Expert Testimony: none
Michael Kaufman, MD
Department of Neurology, Carolinas Medical Center

Speakers Bureau: Acorda, Bayer/Berlex, Biogen Idec, Merck Serono, Novartis, Teva Neuroscience
Consulting: Biogen Idec, Department of Defense, National Multiple Sclerosis Society, Novartis
Royalties: none
Stocks, Bonds, Options: none
Other Equity Interest: none
Patents, Intellectual Property Rights: none
Grant Support: Acorda, Bayer/Berlex, Biogen Idec, Eli Lilly, Genentech, Merck Serono, National Multiple Sclerosis Society, Novartis, Teva Neuroscience
Clinical Procedures: NA
Expert Testimony: NA
Michael Kennelly, MD
Speakers Bureau: Allergan, Astellas, Pfizer, Watson
Consulting: Allergan, AMS, Astellas, Boston Scientific, Coloplast, Hollister, Medtronic, Pfizer, Watson
Royalties: none
Stocks, Bonds, Options: none
Other Equity Interest: none
Patents, Intellectual Property Rights: none
Grant Support: Allergan, AMS, Bard, Coloplast, Contura, Ethicon
Clinical Procedures: none
Expert Testimony: none
Rod Larson
Chief Health Policy Officer, American Academy of Neurology

Nothing to disclose.
Robert Lisak, MD
Parker Webber Chair of Neurology, Professor and Chair of Neurology, Professor of Immunology, Wayne State University

Speakers Bureau: Teva Neuroscience
Consulting: Acorda, Avanir, Bayer Health, Sanofi-Aventis, Teva Neuroscience, Teva Pharmaceuticals
Royalties: none
Stocks, Bonds, Options: none
Other Equity Interest: none
Patents, Intellectual Property Rights: none
Grant Support: Acorda, Genzyme, National Institute of Neurologic Disorders and Stroke, National MS Society, Novartis, Questcor, Sanofi-Aventis, Teva Neuroscience, Teva Pharmaceuticals
Clinical Procedures: none
Expert Testimony: Teva Pharmaceuticals

David H. Mattson, MD, PhD

Professor of Neurology
Director, Indiana University Multiple Sclerosis Center
Indiana University School of Medicine
Indianapolis, IN

Speakers Bureau: Acorda, Bayer, Biogen Idec, EMD Serono, Genzyme, Novartis, Pfizer, Teva Neuroscience
Consulting: none
Royalties: none
Stocks, Bonds, Options: none
Other Equity Interest: none
Patents, Intellectual Property Rights: none
Grant Support: Acorda, Actelion, Biogen Idec, Genentech, Genzyme, Medimmune, Novartis, ONO, Roche, Sanofi-Aventis, Teva Neuroscience, Vaccinex
Clinical Procedures: none
Expert Testimony: none
Kasey Minnis
Director of Operations, Multiple Sclerosis Foundation

Nothing to disclose
Marie Namey, APN, MSCN
Advanced Practice Nurse, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation

Speakers Bureau: Acorda Therapeutics, Biogen Idec, Genzyme, Novartis, Questcor, Teva Neuroscience
Consulting: Acorda Therapeutics, Allergan, Biogen Idec, Genzyme, Novartis, Questcor, Sanofi, Teva Neuroscience
Royalties: none
Stocks, Bonds, Options: none
Other Equity Interest: none
Patents, Intellectual Property Rights: none
Grant Support: none
Clinical Procedures: none
Paul O'Connor MD, MSc, FRCPC
Director, Multiple Sclerosis (MS) Clinic and MS Research and the Evoked Potentials Laboratory, St. Michael's Hospital
Professor of Medicine, Neurology, University of Toronto

Speakers Bureau: none
Consulting: Actelion, Bayer, Biogen Idec, Celgene, EMD Serono, Lilly, Novartis, Receptos, Roche, Sanofi, Teva
Royalties: none
Stocks, Bonds, Options: none
Other Equity Interest: none
Patents, Intellectual Property Rights: none
Grant Support: MS Society of Canada
Clinical Procedures: Evoked Potentials
Expert Testimony: none
Amy Perrin Ross, APN, MSN, CNRN, MSCN
Neuroscience Program Coordinator, Loyola University Chicago
Past President, International Organization of Multiple Sclerosis Nurses

Speakers Bureau: Acorda Therapeutics, Bayer Healthcare, Biogen Idec, EMD Serono, Genzyme, Novartis, Pfizer Inc., Questcor, Teva Pharmaceuticals
Consulting: Acorda Therapeutics, Bayer Healthcare, Biogen Idec, EMD Serono, Genzyme, Novartis, Pfizer Inc., Questcor, Teva Pharmaceuticals
Royalties: none
Stocks, Bonds, Options: none
Other Equity Interest: none
Patents, Intellectual Property Rights: none
Grant Support: none
Clinical Procedures: none
Expert Testimony: none
Cindy Richman
Senior Director of Patient & Healthcare Relations, Multiple Sclerosis Association of America

Nothing to disclose
Hollie Schmidt
Vice President of Scientific Operations, Accelerated Cure Project for Multiple Sclerosis

Nothing to disclose
Paul Tobin
President and CEO, United Spinal Association

Nothing to disclose
Ruth Whitham, MD
Clinical Associate Director, VA MS Center of Excellence West
Professor of Neurology, Oregon Health & Science University

Nothing to disclose
Jerry Wolinsky, MD
Bartels Family and Opal C. Rankin Professor of Neurology, The University of Texas Health Science Center at Houston
Director, Multiple Sclerosis Research Group and Magnetic Resonance Imaging Analysis Center

Speakers Bureau: Serono Symposia International Foundation
Consulting: Actelion Pharmaceuticals Ltd., Astellas, Bayer Schering Pharma, Celgene, Eli Lilly and Company, Hoffman LaRoche, Novartis, Sanofi, Teva Neuroscience, Teva Pharmaceutical Industries Ltd.
Royalties: For monoclonal antibodies out licensed through the University of Texas Health Science Center at Houston to Millipore (Chemicon International) Corporation
Stocks, Bonds, Options: none
Other Equity Interest: none
Patents, Intellectual Property Rights: none
Grant Support: The Clayton Foundation for Research, the National Institutes of Health, the National Multiple Sclerosis Society and Sanofi
Clinical Procedures: none
Expert Testimony: none
Last Updated on Wednesday, 03 September 2014 18:28